![](/img/cover-not-exists.png)
956PA phase Ib and randomised phase II trial of pazopanib with or without fosbretabulin in advanced recurrent ovarian cancer
Morgan, R D, Jayson, G C, Banerjee, S, Clamp, A R, Lyon, A R, Ryder, W D, Hutson, R, Mescallado, N, Orbegoso Aguilar, C, Taylor, S, Tugwood, J, Hall, M, Dive, C, Rustin, G J SVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy285.164
Date:
October, 2018
File:
PDF, 77 KB
2018